Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

2.

Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation.

Rao TS, Currie JL, Shaffer AF, Isakson PC.

Inflammation. 1993 Dec;17(6):723-41.

PMID:
8112831
4.

Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ.

Agents Actions. 1985 Dec;17(2):197-204.

PMID:
3938181
5.
7.

Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.

Rao TS, Yu SS, Djuric SW, Isakson PC.

J Lipid Mediat Cell Signal. 1994 Sep;10(3):213-28.

PMID:
7812673
8.
9.
10.
11.

Role of prostaglandin H synthase isoforms in murine ear edema induced by phorbol ester application on skin.

Sánchez T, Moreno JJ.

Prostaglandins Other Lipid Mediat. 1999 May;57(2-3):119-31.

PMID:
10410383
12.

Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis.

Chang J, Carlson RP, O'Neill-Davis L, Lamb B, Sharma RN, Lewis AJ.

Inflammation. 1986 Sep;10(3):205-14.

PMID:
3091495
13.
15.

Extract and compounds obtained from Mandevilla velutina inhibit arachidonic acid-induced ear oedema in mice, but not rat stomach contraction.

Calixto JB, Zanini Júnior JC, Cruz AB, Yunes RA, Medeiros YS.

Prostaglandins. 1991 May;41(5):515-26.

PMID:
1907393
16.

Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate.

Stanley PL, Steiner S, Havens M, Tramposch KM.

Skin Pharmacol. 1991;4(4):262-71.

PMID:
1789987
17.

A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions.

Bustos G, Ferrándiz ML, Sanz MJ, Payá M, Alcaraz MJ.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Mar;351(3):298-304.

PMID:
7609784
18.

A useful method for differential evaluation of anti-inflammatory effects due to cyclooxygenase and 5-lipoxygenase inhibitions in mice.

Ishii K, Motoyoshi S, Kawata J, Nakagawa H, Takeyama K.

Jpn J Pharmacol. 1994 Aug;65(4):297-303.

19.

Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.

Griswold DE, Marshall PJ, Lee JC, Webb EF, Hillegass LM, Wartell J, Newton J Jr, Hanna N.

Biochem Pharmacol. 1991 Jul 25;42(4):825-31.

PMID:
1907825
20.
Items per page

Supplemental Content

Write to the Help Desk